FDA Adverse Event Injury Summary report: N

PUNCTUA

MDR report key: 2780012 · Received October 10, 2012

Report

Report Number
2124215-2012-13429
Event Type
Injury
Date Received
October 10, 2012
Date of Event
September 3, 2012
Report Date
December 20, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AT THIS TIME THERE IS NO ADDITIONAL INFORMATION. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) CONTINUED TO EXHIBIT HIGH OUT-OF-RANGE SHOCK IMPEDANCE MEASUREMENTS. THE PHYSICIAN OPTED TO MONITOR THE PATIENT WITH CHEST X-RAY EVERY SIX YEARS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE DEVICE REMAINS IN SERVICE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT A RED ALERT WAS DETECTED FOR HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS. SUBSEQUENTLY, ADDITIONAL INFORMATION WAS RECEIVED THAT THIS PATIENT WAS RECENTLY FOLLOWED-UP. A COMMANDED SHOCK WAS PERFORMED TO TEST LEAD INTEGRITY. A 23 JOULE SHOCK WAS DELIVERED, AND THE SHOCK IMPEDANCE REGISTERED AS 74 OHMS. LATITUDE SYSTEM WAS ALSO CHECKED, AND DISPLAYED IMPEDANCE MEASUREMENTS OF SLIGHTLY GREATER THAN 100 OHMS. THE PHYSICIAN DID NOT FEEL ANY FURTHER INTERROGATION WAS NEEDED DUE TO IMPEDANCE MEASUREMENTS BEING WITHIN NORMAL RANGE. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. IT WAS CONFIRMED THE ASSOCIATED RV LEAD WAS A COMPETITOR PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PUNCTUA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F050

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R F050